[Radiotherapy of XXXX ].

@entity1 @entity64 @entity2013 @entity2657 @entity6 @entity2414 @entity5 @entity1313 @entity4614 @entity977 @entity393 @entity652
The aim of this study is to evaluate the use of conventional external radiotherapy in @entity1 with @entity977 . Between October 1970 and May 1998, 27 @entity1 with @entity977 were followed at the Department of Endocrinology and @entity6 of the Hospitais da Universidade de Coimbra. They received radiation therapy at Instituto Portugu  s de Oncologia. Seven of those @entity5 were classified as nonfunctioning @entity652 , 17 as growth-hormone-secreting @entity652 , 2 as @entity2013 and 1 as @entity652 . Twenty-six @entity1 received radiation as adjuvant therapy after incomplete resection and one @entity1 as primary treatment. The majority of these cases were treated using the parallel opposed-field technique with a total dose between 45 and 52 Gy. The @entity1 were submitted, before and after radiotherapy, to a protocol in order to assess the efficacy of this treatment. Some of the results were analyzed. Reduction of @entity5 mass was achieved in 66.6% of nonfunctioning @entity5 and in 25% of the secreting ones. Reduction or stabilization of hormonal levels was achieved in 55% of the cases and normalization in 30%. The average duration of follow-up was 126.3 months. Complications observed: @entity4614 , @entity64 (3 @entity1 ), @entity2657 (1 @entity1 ), @entity2414 (2 @entity1 ) and @entity393 (2 @entity1 ). None of the @entity1 developed @entity1313 .
